Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
"Sex drive" (libido) is a multifactorial behavioral and physiological construct that reflects an individual's motivation or desire to initiate sexual activity[1][3]. It is not a single protein, receptor, or gene product, but rather the emergent output of interactions among neurotransmitters (e.g., dopamine, serotonin, oxytocin, norepinephrine), steroid sex hormones (e.g., testosterone, estrogen, progesterone), neuropeptides, and multiple brain areas including the hypothalamus, limbic system, and relevant cortical regions[1][3][5]. The mesolimbic dopamine pathway is particularly important in promoting sexual motivation, while androgens like testosterone exert powerful modulatory effects[1][3][5]. Disruption in the complex neurobiological circuitry underlying sex drive can be associated with a wide range of diseases or conditions, but "sex drive" itself is not a molecule, receptor, or direct drug target. In summary, "sex drive" is not itself a molecular or therapeutic target, but a global behavior influenced by the coordinated activity of many molecular and neural systems.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Sex drive.